Question 1

Does Wells Fargo own INBX stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Wells Fargo holds 9,563 shares of INBX (Inhibrx Biosciences), worth $906,094.

Question 2

How many shares of INBX does Wells Fargo own?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo holds 9,563 shares of INBX (Inhibrx Biosciences).

Question 3

What is Wells Fargo's INBX position worth?

Accepted Answer

As of its Q2 2026 13F, Wells Fargo's INBX position is worth $906,094.

Question 4

Is Wells Fargo buying or selling INBX?

Accepted Answer

In Q2 2026, Wells Fargo increased its INBX position by 5,625 shares (+142.8%).

Question 5

When did Wells Fargo first buy INBX?

Accepted Answer

Wells Fargo already held INBX in its Q2 2024 13F, the earliest on record, and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	9,563	+142.8%	$906,094	0.0%	$94.75	40
2026-Q1	Decreased	3,938	-63.6%	$264,752	0.0%	$74.33	0
2025-Q4	Increased	10,813	+42.3%	$854,227	0.0%	$77.98	33
2025-Q3	Increased	7,599	+17.5%	$255,934	0.0%	$32.31	18
2025-Q2	Decreased	6,466	-4.7%	$92,270	0.0%	$14.43	0
2025-Q1	Increased	6,781	+2.0%	$94,867	0.0%	$14.12	15
2024-Q4	Increased	6,647	+34.2%	$102,364	0.0%	$15.14	19
2024-Q3	Increased	4,952	+9.5%	$77,548	0.0%	$15.52	16
2024-Q2	New	4,521	-	$64,062	0.0%	$14.17	32

INBX9 quarters

INBX
9 quarters